A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia is a registry-stage clinical asset sponsored by Azienda USL Reggio Emilia - IRCCS in Chronic Myelocytic Leukemia, Erectile Dysfunctions, CVD - Cardiovascular Disease, Tyrosine Kinase Inhibitor. SEO and diligence focus: Tirosin Kinase Inhibitors, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.